AVE — Avecho Biotechnology Balance Sheet
0.000.00%
Last trade - 00:00
- AU$12.68m
- AU$7.35m
- AU$0.47m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 3.21 | 1.87 | 3.26 | 1.47 | 5.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.755 | 0.479 | 1.13 | 0.746 | 1.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4.28 | 2.69 | 4.81 | 2.85 | 7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.18 | 0.233 | 0.336 | 0.468 | 0.316 |
Net Intangible Assets | |||||
Total Assets | 5.32 | 3.35 | 5.25 | 3.35 | 7.32 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.545 | 0.604 | 0.696 | 0.746 | 0.843 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.556 | 0.7 | 0.709 | 0.921 | 0.942 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 4.76 | 2.65 | 4.54 | 2.42 | 6.38 |
Total Liabilities & Shareholders' Equity | 5.32 | 3.35 | 5.25 | 3.35 | 7.32 |
Total Common Shares Outstanding |